Bionomics Limited Stock Current Liabilities
Bionomics Limited fundamentals help investors to digest information that contributes to Bionomics' financial success or failures. It also enables traders to predict the movement of Bionomics Pink Sheet. The fundamental analysis module provides a way to measure Bionomics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bionomics pink sheet.
Bionomics |
Bionomics Limited Company Current Liabilities Analysis
Bionomics' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Bionomics Current Liabilities | 11 M |
Most of Bionomics' fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bionomics Limited is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
CompetitionIn accordance with the recently published financial statements, Bionomics Limited has a Current Liabilities of 11 M. This is 99.37% lower than that of the Healthcare sector and 97.97% lower than that of the Biotechnology industry. The current liabilities for all United States stocks is 99.86% higher than that of the company.
Did you try this?
Run Transaction History Now
Transaction HistoryView history of all your transactions and understand their impact on performance |
All Next | Launch Module |
Bionomics Fundamentals
Return On Equity | -0.42 | |||
Return On Asset | -0.18 | |||
Operating Margin | (2.91) % | |||
Current Valuation | 27.83 M | |||
Shares Outstanding | 1.35 B | |||
Shares Owned By Insiders | 6.00 % | |||
Shares Owned By Institutions | 48.96 % | |||
Price To Earning | (34.09) X | |||
Price To Book | 1.24 X | |||
Price To Sales | 8.29 X | |||
Revenue | 263.63 K | |||
Gross Profit | (9.94 M) | |||
EBITDA | (21.92 M) | |||
Net Income | (21.76 M) | |||
Cash And Equivalents | 33.56 M | |||
Cash Per Share | 0.03 X | |||
Total Debt | 693.62 K | |||
Debt To Equity | 0.01 % | |||
Current Ratio | 12.46 X | |||
Book Value Per Share | 0.04 X | |||
Cash Flow From Operations | (21.76 M) | |||
Earnings Per Share | (0.01) X | |||
Number Of Employees | 22 | |||
Beta | 2.18 | |||
Market Capitalization | 29.11 M | |||
Total Asset | 65.31 M | |||
Retained Earnings | (103 M) | |||
Working Capital | 47 M | |||
Current Asset | 58 M | |||
Current Liabilities | 11 M | |||
Z Score | 23.2 | |||
Net Asset | 65.31 M |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Bionomics Pink Sheet
If you are still planning to invest in Bionomics Limited check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bionomics' history and understand the potential risks before investing.
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |